| PROCYSBI 300 mg gastro-resistant granules EU/1/13/861/004 |
Mercaptamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| PROCYSBI 75 mg gastro-resistant granules EU/1/13/861/003 |
Mercaptamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| PROCYSBI 75 mg gastro-resistant hard capsules EU/1/13/861/002 |
Cysteamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| Produodopa 240 mg/ml + 12 mg/ml solution for infusion PA1824/002/003 |
Foslevodopa, Foscarbidopa |
AbbVie Limited |
Marketed |
| Profloxin 250 mg film-coated tablets PA0126/203/001 |
Ciprofloxacin |
Clonmel Healthcare Ltd |
Marketed |
| Profloxin 500 mg film-coated tablets PA0126/203/002 |
Ciprofloxacin |
Clonmel Healthcare Ltd |
Marketed |
| Progesterone 400 mg pessaries PA1330/027/001 |
Progesterone |
Gedeon Richter Plc |
Not marketed |
| Prograf 0.5 mg hard capsules PA1241/014/001 |
Tacrolimus |
Astellas Pharma Co. Limited |
Marketed |
| Prograf 0.5 mg hard capsules PPA0465/435/001 |
Tacrolimus |
PCO Manufacturing Ltd. |
— |
| Prograf 0.5 mg hard capsules PPA1463/165/001 |
Tacrolimus |
IMED Healthcare Ltd., |
— |
| Prograf 1 mg hard capsules PA1241/014/002 |
Tacrolimus |
Astellas Pharma Co. Limited |
Marketed |
| Prograf 5 mg hard capsules PA1241/014/003 |
Tacrolimus |
Astellas Pharma Co. Limited |
Marketed |
| Prograf 5 mg hard capsules PPA1463/165/002 |
Tacrolimus |
IMED Healthcare Ltd., |
— |
| Prograf 5 mg/ml concentrate for solution for infusion PA1241/014/004 |
Tacrolimus |
Astellas Pharma Co. Limited |
Marketed |
| ProHance, 279.3 mg/ml, Solution for Injection, 10 ml vial PA0788/001/002 |
Gadoteridol |
Bracco International B.V. |
Marketed |
| ProHance, 279.3 mg/ml, Solution for Injection, 15 ml vial PA0788/001/003 |
Gadoteridol |
Bracco International B.V. |
Not marketed |
| ProHance, 279.3 mg/ml, solution for injection, 20 ml vial PA0788/001/004 |
Gadoteridol |
Bracco International B.V. |
Marketed |
| Prolastin 4000 mg, powder and solvent for solution for infusion PA1405/002/002 |
Human alpha1-proteinase inhibitor |
Grifols Deutschland GmbH |
Not marketed |
| Prolastin 5000 mg, powder and solvent for solution for infusion PA1405/002/003 |
Human alpha1-proteinase inhibitor |
Grifols Deutschland GmbH |
Not marketed |
| Prolastin1000mg, powder and solvent for solution for infusion PA1405/002/001 |
Alpha-1-proteinase inhibitor |
Grifols Deutschland GmbH |
Marketed |
| Prolia 60 mg solution for injection in pre-filled syringe EU/1/10/618/1-4 |
Denosumab |
Amgen Europe B.V., |
— |
| Prometax 1.5 mg hard capsules EU/1/98/092/001-003 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 13.3 mg/24 h transdermal patch EU/1/98/092/027-030 |
Rivastigmine |
Almirall, S.A. |
— |
| Prometax 2 mg/ml oral solution EU/1/98/092/013 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 3.0 mg hard capsules EU/1/98/092/004-006 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 4.5 mg hard capsules EU/1/98/092/007-009 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 4.6 mg/24 h transdermal patch EU/1/98/092/19-22 |
Rivastigmine |
Almirall, S.A. |
— |
| Prometax 6.0 mg hard capsules EU/1/98/092/010-012 |
Rivastigmine hydrogen tartrate |
Almirall, S.A. |
— |
| Prometax 9.5 mg/24 h transdermal patch EU/1/98/092/23-26 |
Rivastigmine |
Almirall, S.A. |
— |
| Propafenone Hydrochloride 150mg Film-coated tablets PA2315/116/001 |
Propafenone hydrochloride |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Propafenone Hydrochloride 300mg Film-coated tablets PA2315/116/002 |
Propafenone hydrochloride |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Propess 10 mg vaginal delivery system PA1009/029/001 |
Dinoprostone |
Ferring Ireland Ltd |
Marketed |
| Propinorm XL 30 mg Modified-Release Capsules PA0803/005/001 |
Propiverine hydrochloride |
APOGEPHA Arzneimittel GmbH |
Not marketed |
| Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule PA2059/055/001 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, vial PA2059/055/002 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propofol 1% (10 mg/ml) emulsion for injection/infusion PA2059/017/001 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Propofol 1% (10 mg/ml) emulsion for injection/infusion in pre-filled syringe PA2059/017/004 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Propofol 10 mg/ml Emulsion for injection/infusion PA2299/038/001 |
Propofol |
Baxter Holding B.V. |
Marketed |
| Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule PA2059/055/003 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, vial PA2059/055/004 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propofol 2% (20 mg/ml) emulsion for injection/infusion PA2059/017/003 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Propofol 2% (20 mg/ml) emulsion for injection/infusion in pre-filled syringe PA2059/017/005 |
Propofol |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Propofol 20 mg/ml Emulsion for injection/infusion PA2299/038/002 |
Propofol |
Baxter Holding B.V. |
Marketed |
| Propofol-Lipuro 1% (10 mg/ml) emulsion for injection or infusion PA0736/018/001 |
Propofol |
B. Braun Melsungen AG |
Marketed |
| Propofol-Lipuro 1% (10 mg/ml) emulsion for injection or infusion PA0736/018/002 |
Propofol |
B. Braun Melsungen AG |
Marketed |
| Propofol-Lipuro 2% (20 mg/ml) emulsion for injection or infusion PA0736/018/003 |
Propofol |
B. Braun Melsungen AG |
Marketed |
| Propranolol 10 mg film-coated tablets PPA0465/509/001 |
Propranolol hydrochloride |
PCO Manufacturing Ltd. |
— |
| Propranolol 40 mg film-coated tablets PPA0465/509/002 |
Propranolol hydrochloride |
PCO Manufacturing Ltd. |
— |
| Propranolol Azure 10 mg film-coated tablets PA22871/031/001 |
Propranolol hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Propranolol Azure 40 mg film-coated tablets PA22871/031/002 |
Propranolol hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |